This HTML5 document contains 114 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n9http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38777264
rdf:type
wikibase:Item
schema:description
artigo científico teaduslik artikkel научна статия scientific article published on 18 April 2016 articol științific мақолаи илмӣ scienca artikolo 2016年論文 2016年论文 2016年论文 artikulong pang-agham tieteellinen artikkeli vedecký článok vitenskapelig artikkel videnskabelig artikel 2016年論文 vetenskaplig artikel artigo científico scientific article published on 18 April 2016 επιστημονικό άρθρο 2016年論文 2016年の論文 2016年论文 2016년 논문 bilimsel makale наукова стаття, опублікована у квітні 2016 מאמר מדעי article scientifique სამეცნიერო სტატია vitskapeleg artikkel artikull shkencor artículo científico publicado en 2016 artykuł naukowy научни чланак 2016 nî lūn-bûn 2016年论文 научная статья wissenschaftlicher Artikel bài báo khoa học 2016年論文 tudományos cikk artigo científico scientific article published on 18 April 2016 vědecký článek articolo scientifico 2016年論文 บทความทางวิทยาศาสตร์ 2016年论文 artikel ilmiah 2016年论文 artículu científicu espublizáu en 2016 научни чланак wetenschappelijk artikel article científic article scientific مقالة علمية نشرت في 18 أبريل 2016 ১৮ এপ্রিল ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak
p:P577
wds:Q38777264-B10F7A81-6560-40D2-AFCD-A1F9F69C6E20
wdt:P577
2016-04-18T00:00:00Z
p:P407
wds:Q38777264-3E76DE4D-B2F2-48C1-9588-5E96BBEEBD2B
wdt:P407
wd:Q1860
p:P2093
wds:Q38777264-67C8516E-7E31-4F5F-BD2E-6D25C6985C6A wds:Q38777264-5F6A5278-8336-4CDC-B8D2-59B4CC22F018 wds:Q38777264-7E035B25-97E3-4250-A203-C80BBBF7E468 wds:Q38777264-A8E9EAD0-49AA-46D1-856C-E770BFE09C60 wds:Q38777264-EB18505D-AAEC-47A1-A7CF-E61FF82B9D03 wds:Q38777264-B6762D6A-86DE-4222-8972-29F15BAF6067 wds:Q38777264-BC2B6F59-EEA9-4326-B88F-88CA593625AC wds:Q38777264-28B6247C-11D8-4337-879A-980F43DCFA46 wds:Q38777264-32BCA564-9460-4E76-93A2-71F5FB81E496 wds:Q38777264-F1C06867-1D93-4F1A-B5C2-76C8A12523B8
wdt:P2093
Masaki Yasukawa Hiroki Tanaka Fumihiro Ochi Junichi Mineno Sachiko Okamoto Kazushi Tanimoto Kiyotaka Kuzushima A John Barrett Nicholas Casey Hiroshi Fujiwara
rdfs:label
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
skos:prefLabel
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
schema:name
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
p:P50
wds:Q38777264-14170C35-9122-4401-936D-AD4955A2DEE9 wds:Q38777264-EBD5F02D-9F9C-4B55-8C80-AD2D9F90ECFE
wdt:P50
wd:Q80321542 wd:Q71004076
p:P1476
wds:Q38777264-37B73AF3-1BBE-48B5-9875-1D960DA5D7C5
wdt:P1476
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
p:P304
wds:Q38777264-B4CADF03-F45A-4616-93CA-8583C5890102
wdt:P304
4405-4416
p:P31
wds:Q38777264-51DCE055-B452-4EF1-8378-F2DAEF7339F0
wdt:P31
wd:Q13442814
p:P698
wds:Q38777264-40543976-7D95-4C7F-A422-178EB4C39AE0
wdtn:P698
n12:27091408
wdt:P698
27091408
p:P1433
wds:Q38777264-DF8C4EF3-5C7D-44FC-BCD7-9B08CEEF9C09
wdt:P1433
wd:Q332253
p:P433
wds:Q38777264-1296E8FA-047C-4E84-A13E-2AE1E11D4853
p:P478
wds:Q38777264-7A82D486-2C0D-4736-B80C-306F49DC3B1C
wdt:P433
17
wdt:P478
22
p:P356
wds:Q38777264-3CF3EE95-502F-4AA3-824E-7FD8AE753DD7
wdtn:P356
n9:1078-0432.CCR-15-2714
wdt:P356
10.1158/1078-0432.CCR-15-2714